September 12, 2017

AARDA’s letter to the Centers for Medicare and Medicaid Services (CMS) regarding biosimilars

AARDA works to advocate for all those who are living with autoimmune diseases. As part of our advocacy efforts, AARDA submitted a comment letter on September […]